Schedule 13G ownership disclosure
Candel Therapeutics Inc
Security class unavailable · CUSIP: 137404109
Event date: 2024-12-13
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-24-129285
- Form type
- SC 13G
- Filer
- CVI Investments, Inc.
- CIK
- CIK 1649553
- Filed
- Dec 17, 2024
- Reporting period
- Dec 13, 2024
- Description
- Schedule 13G beneficial ownership